| Metformin |
5mM |
30 minutes |
mouse; C57BL/6J |
isolated skeletal muscle mitochondria |
Meassurement of alpha-ketoglutarate concentration; compared with MCF10A |
affect |
Positive |
p < 0.05 |
172 |
| Metformin |
5mM |
30 minutes |
mouse; C57BL/6J |
isolated skeletal muscle mitochondria |
Meassurement of alpha-ketoglutarate concentration; compared with MCF10A |
affect |
Positive |
p < 0.05 |
172 |
| Metformin |
5mM |
30 minutes |
mouse; C57BL/6J |
isolated skeletal muscle mitochondria |
Meassurement of succinate concentration |
decrease |
Positive |
p < 0.05 |
172 |
| Metformin |
5mM |
30 minutes |
mouse; C57BL/6J |
isolated skeletal muscle mitochondria |
Meassurement of succinate concentration |
decrease |
Positive |
p < 0.05 |
172 |
| Fluoroacetate |
|
|
|
|
|
affect |
Positive |
|
173 |
| Rosiglitazone |
1uM |
24 and 48 hours |
Murine |
adipocytes |
Citrate Synthase Activity |
affect |
Positive |
|
179 |
| Polymyxin B |
1.6 μg/ml |
|
Mycobacterium smegmatis |
membrane-bound dehydrogenases |
|
affect |
Positive |
IC50 |
76 |
| nanaomycin a |
31 μg/ml |
|
Mycobacterium smegmatis |
membrane-bound dehydrogenases |
|
affect |
Positive |
IC50 |
76 |
| oxaloacetate |
|
|
|
|
|
affect |
Positive |
|
79 |
| malate |
|
|
|
|
|
affect |
Positive |
|
79 |
| citrate |
|
|
|
|
|
affect |
Positive |
|
79 |
| fumarate |
|
|
|
|
|
affect |
Positive |
|
79 |
| Metformin |
0.5mM |
24 hours |
human |
MCF10A |
Meassurement of citrate concentration; compared with MCF10A |
affect |
Positive |
p < 0.05 |
172 |
| Metformin |
0.5mM |
24 hours |
human |
MCF7 |
Meassurement of citrate concentration; compared with MCF10A |
affect |
Positive |
p < 0.05 |
172 |
| Metformin |
0.5mM |
24 hours |
human |
MCF10A |
Meassurement of isocitrate concentration; compared with MCF10A |
affect |
Positive |
p < 0.05 |
172 |
| Metformin |
0.5mM |
24 hours |
human |
MCF7 |
Meassurement of isocitrate concentration; compared with MCF10A |
affect |
Positive |
p < 0.05 |
172 |
| Metformin |
0.5mM |
24 hours |
human |
MCF10A |
Meassurement of alpha-ketoglutarate concentration; compared with MCF10A |
affect |
Positive |
p < 0.05 |
172 |
| Fluoroacetate |
|
|
|
|
|
|
Positive |
|
251 |
| Metformin |
0.5mM |
24 hours |
human |
MCF7 |
Meassurement of alpha-ketoglutarate concentration; compared with MCF10A |
affect |
Positive |
p < 0.05 |
172 |
| Tianeptine |
0.5 mM |
|
mouse |
|
The activity of the tricarboxylic acid cycle, assessed as the in vitro formation of [14C]CO2 from [1-14C]acetylcoenzyme A in vitro. |
affect |
Positive |
|
237 |
| tetracyclines |
|
|
mouse |
liver mitochondria |
Tricarboxylic acid cycle activity was assessed by the in vitro formation of [14C]CO2 from [1-14C]acetylcoenzyme A by mouse liver mitochondria. |
affect |
Positive |
|
236 |
| Metformin |
5mM |
30 minutes |
mouse; C57BL/6J |
isolated skeletal muscle mitochondria |
Meassurement of citrate concentration; compared with MCF10A |
affect |
Positive |
p < 0.05 |
172 |
| Metformin |
5mM |
30 minutes |
mouse; C57BL/6J |
isolated skeletal muscle mitochondria |
Meassurement of citrate concentration; compared with MCF10A |
affect |
Positive |
p < 0.05 |
172 |